ESMO: European Society for Medical Oncology

  1. Most of the studies included in the analysis were published in influential journals
  2. New technologies in immuno-oncology that are set to benefit many more patients with cancer are being showcased at the ESMO Immuno-Oncology Congress, to be held 13-16 December in Geneva, Switzerland
  3. Researchers predict that death rates from cancer will fall in 2018 in Australasian countries and in Russia. However, a greater proportion of the population will die in Russia from the disease than in any of the other countries, mainly because of the large numbers of men who still smoke.
  4. It was also expected to be used in combination with bevacizumab to treat advanced or metastatic RCC 
  5. Approval is based on results from the IMpower150 trial